Literature DB >> 7971745

Human TRP-1 has tyrosine hydroxylase but no dopa oxidase activity.

H Zhao1, Y Zhao, J J Nordlund, R E Boissy.   

Abstract

Human TRP-1 has been immunopurified from normal human melanocytes cultured from black neonatal subjects and used to investigate the catalytic function of TRP-1 for the two substrates, L-tyrosine and L-DOPA. Immunopurified TRP-1 did not demonstrate DOPA staining on SDS/PAGE nor DOPA oxidase (DO) activity with either routine or modified assays. The purified TRP-1 also demonstrated no tyrosine hydroxylase (TH) activity using the routine Pomerantz assay. However, there was apparent TH activity exhibited by immunopurified TRP-1 under conditions with low tyrosine concentration (< or = 0.8 microCi/ml of 3H-tyrosine), prolonged incubation time (i.e., overnight) and in the absence of the cofactor L-DOPA. Using these latter specific conditions, TH activity was also detected in cell lysates from a tyrosinase-negative albino melanocyte line which exhibited no TH activity with the routine Pomerantz assay. In addition, TH activity under low substrate assay conditions was not exhibited in a melanocyte line derived from a TRP-1 deficient, Brown albino individual. However, the absence of TH in this Brown albino cell line could be compensated for by the addition of L-DOPA to the assay. These results suggested that TRP-1 has some tyrosine hydroxylase but no DOPA oxidase activity. We propose that one function of TRP-1 is to modulate tyrosinase activity by making DOPA available as a cofactor to perpetuate the initial steps in melanogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7971745     DOI: 10.1111/j.1600-0749.1994.tb00040.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  8 in total

1.  Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".

Authors:  R E Boissy; H Zhao; W S Oetting; L M Austin; S C Wildenberg; Y L Boissy; Y Zhao; R A Sturm; V J Hearing; R A King; J J Nordlund
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

Review 2.  Albinism: modern molecular diagnosis.

Authors:  S M Carden; R E Boissy; P J Schoettker; W V Good
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

3.  The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase.

Authors:  C Olivares; C Jiménez-Cervantes; J A Lozano; F Solano; J C García-Borrón
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

4.  A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo.

Authors:  Prashiela Manga; David Sheyn; Fan Yang; Rangaprasad Sarangarajan; Raymond E Boissy
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

5.  Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligo.

Authors:  L M Austin; R E Boissy
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

6.  In silico screening and molecular dynamics simulation of disease-associated nsSNP in TYRP1 gene and its structural consequences in OCA3.

Authors:  Balu Kamaraj; Rituraj Purohit
Journal:  Biomed Res Int       Date:  2013-06-19       Impact factor: 3.411

7.  Melanocytic galectin-3 is associated with tyrosinase-related protein-1 and pigment biosynthesis.

Authors:  Allison Chalupa; Amy Koshoffer; Emily Galan; Lan Yu; Fu-Tong Liu; Raymond E Boissy
Journal:  J Invest Dermatol       Date:  2014-07-23       Impact factor: 8.551

Review 8.  Mutational analysis of oculocutaneous albinism: a compact review.

Authors:  Balu Kamaraj; Rituraj Purohit
Journal:  Biomed Res Int       Date:  2014-06-29       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.